What you should know
- New York City on Wednesday reported its first “significant allergic reaction” in a healthcare worker who received the Pfizer COVID-19 vaccine, the only adverse response the city has received of the more than 30,000 injections given to the city. date.
- The worker has been treated and is in stable condition, city officials said.
- Allergic reactions to the Pfizer vaccine have been reported in clinical trials and since the FDA granted emergency use authorization earlier this month, but they remain rare.
—
NEW YORK – New York City reported Wednesday its first “significant allergic reaction” in a healthcare worker who received the Pfizer COVID-19 vaccine, the only adverse response the city has received of more than 30,000 injections. managed to date.
The worker has been treated and is in stable condition, city officials said. Allergic reactions to the Pfizer vaccine have been reported in clinical trials and since the Food and Drug Administration (FDA) granted emergency use authorization earlier this month, but they remain rare. .
Health officials say they are closely monitoring reports of more serious side effects in collaboration with the Centers for Disease Control and Prevention (CDC). Meanwhile, it will continue to move forward with vaccine distribution to ensure front-line workers and nursing home residents and staff are protected from the virus, health officials said in a statement.
No specific details were available on the allergic response of the affected worker. Rare allergic reactions were reported in Britain before Pfizer / BioNTech launched in the US, which has since reported similar and rare reactions. Three of them involved health workers in Alaska.
Earlier this week, an official with the National Institute of Allergy and Infectious Diseases told CNBC that the US is studying why some people have suffered severe allergic reactions after receiving the vaccines.
The study, which is still in the early planning stages, is expected to include “several hundred” people who have a history of severe allergic reactions, Alkis Togias, head of the Alkis Togias Branch of Allergy, Asthma and Biology, told CNBC. the NIAID Airways. While people who received the Pfizer injection have reported rare reactions, the study can look at vaccines made by both Pfizer and Moderna.
The hope is that it will take off in a matter of weeks, officials told CNBC.
– .
